Tumorigenicity study of sodium erythorbate administered orally to mice. 1989

K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka

Sodium erythorbate (SE) was administered at concentrations of 0, 1.25, or 2.5% (maximum tolerated dose, MTD) in the drinking-water to groups of 50 male B6C3F1 mice respectively. Female groups, each consisting of 50 mice, received SE in the drinking-water at concentrations of 0, 2.5 or 5% (MTD). Treatment continued for 96 wks and the experiment was terminated during wk 110. Tumors were observed at various sites including the liver, hematopoietic system, lung and soft tissue. However, at any of the sites, the tumor incidence, the time to death with tumors or the histological distribution of tumors did not differ significantly from those in the untreated control group. Thus, the present study did not demonstrate a tumorigenic effect of SE on B6C3F1 mice by means of oral administration.

UI MeSH Term Description Entries
D008297 Male Males
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D001205 Ascorbic Acid A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. Vitamin C,Ascorbic Acid, Monosodium Salt,Ferrous Ascorbate,Hybrin,L-Ascorbic Acid,Magnesium Ascorbate,Magnesium Ascorbicum,Magnesium di-L-Ascorbate,Magnorbin,Sodium Ascorbate,Acid, Ascorbic,Acid, L-Ascorbic,Ascorbate, Ferrous,Ascorbate, Magnesium,Ascorbate, Sodium,L Ascorbic Acid,Magnesium di L Ascorbate,di-L-Ascorbate, Magnesium
D015197 Carcinogenicity Tests Tests to experimentally measure the tumor-producing/cancer cell-producing potency of an agent by administering the agent (e.g., benzanthracenes) and observing the quantity of tumors or the cell transformation developed over a given period of time. The carcinogenicity value is usually measured as milligrams of agent administered per tumor developed. Though this test differs from the DNA-repair and bacterial microsome MUTAGENICITY TESTS, researchers often attempt to correlate the finding of carcinogenicity values and mutagenicity values. Tumorigenicity Tests,Carcinogen Tests,Carcinogenesis Tests,Carcinogenic Activity Tests,Carcinogenic Potency Tests,Carcinogen Test,Carcinogenesis Test,Carcinogenic Activity Test,Carcinogenic Potency Test,Carcinogenicity Test,Potency Test, Carcinogenic,Potency Tests, Carcinogenic,Test, Carcinogen,Test, Carcinogenesis,Test, Carcinogenic Activity,Test, Carcinogenic Potency,Test, Carcinogenicity,Test, Tumorigenicity,Tests, Carcinogen,Tests, Carcinogenesis,Tests, Carcinogenic Activity,Tests, Carcinogenic Potency,Tests, Carcinogenicity,Tests, Tumorigenicity,Tumorigenicity Test
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
November 1985, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
June 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
February 1990, Japanese journal of cancer research : Gann,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
January 1988, Japanese journal of cancer research : Gann,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
June 1981, Bulletin of environmental contamination and toxicology,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
August 1988, The Journal of pharmacy and pharmacology,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
December 2023, International journal of toxicology,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
December 2017, Experimental and therapeutic medicine,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
July 1958, Proceedings of the staff meetings. Mayo Clinic,
K Inai, and H Akamizu, and R Eto, and T Nishida, and K Ohe, and T Kobuke, and S Nambu, and K Matsuki, and S Tokuoka
September 1970, Infection and immunity,
Copied contents to your clipboard!